D'Agostino, Ilaria, Giacchello, Ilaria, Nannetti, Giulio ![]() |
Preview |
PDF
- Accepted Post-Print Version
Download (998kB) | Preview |
Abstract
The limited treatment options against influenza virus along with the growing public health concerns regarding the continuous emergence of drug-resistant viruses make essential the development of new anti-flu agents with novel mechanisms of action. One of the most attractive targets is the interaction between two subunits of the RNA-dependent RNA polymerase, PA and PB1. Herein we report the rational design of hybrid compounds starting from a 3-cyano-4,6-diphenylpyridine scaffold recently identified as disruptor of PA-PB1 interactions. Guided by the previously reported SAR data, a library of amino acid derivatives was synthesized. The biological evaluation led to the identification of new PA-PB1 inhibitors, that do not show appreciable toxicity. Molecular modeling shed further lights on the inhibition mechanism of these compounds.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Publisher: | Elsevier |
ISSN: | 0223-5234 |
Date of First Compliant Deposit: | 20 September 2018 |
Date of Acceptance: | 11 August 2018 |
Last Modified: | 26 Nov 2024 18:15 |
URI: | https://orca.cardiff.ac.uk/id/eprint/115115 |
Citation Data
Cited 22 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |